Post Study Continuation of C7 for G1D

Juan Pascual

Status

Conditions: Glucose Transporter Type 1 Deficiency Syndrome; Glut1 Deficiency Syndrome

Treatments: Drug: Triheptanoin

Study type: Expanded Access

Funder types: Other

Identifiers

NCT02018302

UTSW 082013-016

Details and patient eligibility

About

This protocol provides ongoing access to triheptanoin for patients who did complete an initial pilot protocol, and provides the opportunity to collect long-term safety data from patients treated with triheptanoin.

Full description

Only patients who completed the initial pilot study were eligible. The study is ongoing with these patients only.

Sex: All

Ages: 1 month to 28 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients enrolled in the pilot trial (UTSW 122010-186)

Exclusion criteria

• Subjects who did not complete the pilot trial (UTSW 122010-186)